NASDAQ
AHCO
Last Price
US $10.19
KEY FIGURES
MKT CAP
$1.4B
EPS
TTM
$-0.59
PEG
TTM
N/M
P/E
TTM
N/M
P/S
TTM
0.48x
YIELD
0.00%
GROWTH
Revenue Y/Y
25.16%
(FY vs FY)
EBITDA Y/Y
Cash Flow (DCF)
Fair Value
Market $10.19
19.92%
Default assumptions
EBITDA Multiple
Fair Value
Market $10.19
24.83%
Default assumptions
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
AdaptHealth Corp. cash flow to debt ratio of 31.63% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.
Financial risk - Healthy cash flow growth.
AdaptHealth Corp.'s free cash flow has decreased -6.96% from $235.78M last year to $219.38M, signaling decreasing performance
Financial risk - Healthy debt to equity ratio.
AdaptHealth Corp.'s debt to equity ratio is 1.33, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial stability - Healthy debt to equity ratio development.
AdaptHealth Corp.'s debt has decreased relative to shareholder equity from 1.36 last year to 1.33 today, signaling strengthened financials
Financial risk - Net debt/EBITDA.
AdaptHealth Corp. has a net debt to EBITDA ratio of 3.57x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk
Financial stability - ICR.
AdaptHealth Corp.'s interest coverage ratio of 2.02 indicates that earnings with margin can cover interest payments on company debt
Financial risk - Profit margin growth.
AdaptHealth Corp.'s profit margin has decreased (-200.39%) in the last year from 2.77% to -2.78%, signaling decreasing performance
Financial stability - Short term assets vs short term liabilities.
AdaptHealth Corp.'s short-term assets of $728.90M exceed its short-term liabilities of $712.39M
Decreasing performance - ROA.
AdaptHealth Corp.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
AdaptHealth Corp.'s return on equity of -5.11%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
AdaptHealth Corp.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Increasing performance - Earnings stability.
AdaptHealth Corp. had positive net income in 3.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
AdaptHealth Corp. has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
AdaptHealth Corp. has a free cash flow yield of 15.82%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Decreasing performance - Healthy earnings growth.
AdaptHealth Corp.'s yearly earnings has decreased -178.29% since last year from $90.42M to $-70.79M, signaling decreasing performance
Decreasing performance - Healthy revenue growth.
AdaptHealth Corp.'s yearly revenue has decreased -0.49% since last year from $3.26G to $3.24G, signaling decreasing performance
Increasing performance - ROIC.
ROIC 5.52% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.
Increasing performance - 3-year revenue CAGR.
AdaptHealth Corp.'s 3-year revenue CAGR of 2.99% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
AdaptHealth Corp. had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
AdaptHealth Corp. had positive ROE in 3.00 out of 5 years, indicating consistent and reliable returns on equity
Undervalued - DCF valuation.
AdaptHealth Corp. is undervalued relative to its fair value price of 12.22 based on Discounted Cash Flow model
Overvalued - Earnings yield.
AdaptHealth Corp. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Undervalued - EBITDA valuation.
AdaptHealth Corp. is undervalued relative to its fair value price of 12.72 based on EBITDA multiple model
Undervalued - EV/EBITDA.
AdaptHealth Corp. has an EV/EBITDA ratio of 6.32x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Overvalued - PEG ratio value.
AdaptHealth Corp. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Undervalued - P/B ratio.
AdaptHealth Corp. has a price-to-book ratio of 0.91x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
AdaptHealth Corp. has a price-to-sales ratio of 0.48x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-5.11%
Return on equity
ROIC: 5.52%
Valuation History
-17.3X
Price to Earnings
EV/EBITDA: 7.2X
Cash flow
Profit margin
-
(FY vs FY)
Cash flow Y/Y
7.07%
(FY vs FY)
Base valuations use default assumptions. Customize in the Valuator.